Drug Shortage Report for APO-TADALAFIL

Last updated on 2017-10-11 History
Report ID 20245
Drug Identification Number 02422115
Brand name APO-TADALAFIL
Common or Proper name TADALAFIL
Company Name APOTEX INC
Active Ingredient(s) TADALAFIL
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 4 BLS
ATC code G04BE
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-08-18
Estimated end date 2017-10-20
Actual end date 2017-10-10
Shortage status Resolved
Updated date 2017-10-11
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2017-10-11 French Compare
v9 2017-10-11 English Compare
v8 2017-09-25 French Compare
v7 2017-09-25 English Compare
v6 2017-09-25 French Compare
v5 2017-09-25 English Compare
v4 2017-09-22 French Compare
v3 2017-09-22 English Compare
v2 2017-08-24 French Compare
v1 2017-08-24 English Compare